Immunome Cash from Financing (TTM) Analysis

Immunome Inc (IMNM)

14.97 +0.28 (+1.91%) USD | NASDAQ | May 02, 16:00

14.94 -0.02 (-0.17%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	116.41M
September 30, 2023	60.91M
June 30, 2023	0.034M
March 31, 2023	0.034M
December 31, 2022	0.032M
September 30, 2022	-0.163M
June 30, 2022	0.422M

Date	Value
March 31, 2022	27.72M
December 31, 2021	27.77M
September 30, 2021	67.09M
June 30, 2021	66.12M
March 31, 2021	49.18M
December 31, 2020	49.94M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.163M

Minimum

Sep 2022

116.41M

Maximum

Dec 2023

35.81M

Average

27.77M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks